19 November 2019Sol Global Investments (SOL.C) 40.7% ownership of Heavenly Rx could…Joseph Morton SOL.C Sol Global Investments’ (SOL.C) 40.7% owned subsidiary Heavenly Rx, inked a memorandum of understanding (MOU) today to go public using Therapix Biosciences (TRPX.Q) for their reverse takeover. Sol originally…